Blood cancers

Blood cancers are abnormally growing cells that arise from cells in the blood system. Leukaemia, lymphoma and myeloma are common types of blood cancer.


Our researchers are working to understand why blood cancers arise, and developing better treatments. Our goal is to improve the survival of people with blood cancer.

Our blood cancer research

WEHI’s research into blood cancer spans from investigating the molecules that drive blood cancers through to drug development and testing, and involvement in clinical trials.

We particularly focus on:

  • Defining the genetic and molecular changes that cause blood cancers
  • Uncovering how blood cancers become resistant to treatment
  • Discovering molecular targets in blood cancers
  • Developing and testing new drugs to treat blood cancers
  • Undertaking pre-clinical and clinical studies of new therapies for blood cancer.

WEHI’s blood cancer research spans more than 60 years and has underpinned the development of new medicines that have improved treatment for millions of patients.

Above: Clinician scientist Dr Mary Ann Anderson is focussing on new treatments for blood cancers
Sign up to our quarterly newsletter Illuminate

Find out about recent discoveries, community supporters and more.

Illuminate Winter 2024
View the current issue